QC Analyst I - Biochemistry (2nd Shift)
Danaher Corporation
Summary
The Analyst I, QC Biochemistry is responsible for executing QC laboratory testing and associated duties that support accurate, reliable quality control results.
Job description
This position reports to the Supervisor QC Biochemistry and is part of the Quality Control department located in Fargo, ND and will be an on-site role.
In this role, you will have the opportunity to:
- Independently perform established QC assays and non-routine testing as assigned.
- Accurately document results and perform data entry and self-review.
- Assist with equipment maintenance and calibration.
The essential requirements of the job include:
- Bachelor of Science in Biology, Biochemistry, or related field required.
- Independently perform established QC assays and non-routine testing as assigned.
- Accurately document results and perform data entry and self-review and adequately document and compare test results against specifications.
It would be a plus if you also possess previous experience in:
- Working in a laboratory environment.
- Applying basic math and algebra in a scientific setting.
- Operating precision measuring tools and laboratory equipment.
Requirements
- Bachelor of Science in Biology, Biochemistry, or related field required
- Independently perform established QC assays and non-routine testing as assigned
- Accurately document results and perform data entry and self-review
- Adequately document and compare test results against specifications
- Working in a laboratory environment
- Applying basic math and algebra in a scientific setting
- Operating precision measuring tools and laboratory equipment
Benefits
- Health care program
- Paid time off
Company overview
Danaher Corporation is a leading global science and technology innovator headquartered in Washington, D.C., specializing in biotechnology, life sciences, and diagnostics. Founded in 1984 by brothers Steven and Mitchell Rales, the company has evolved from its origins as a manufacturing conglomerate into a premier healthcare technology organization with approximately 63,000 employees worldwide. Danaher operates through three core divisions: biotechnology (28% of revenues), which develops products for therapeutic development; life sciences (31% of revenues), focused on disease identification, new therapies, and drug testing/manufacturing; and diagnostics (41% of revenues), providing instruments, consumables, and software for disease diagnosis. The company's portfolio includes renowned brands such as Beckman Coulter, Cytiva, Pall Corporation, Cepheid, Leica Microsystems, and Abcam, serving pharmaceutical companies, biotechnology firms, healthcare providers, and research institutions globally. Danaher is distinguished by its Danaher Business System (DBS), a continuous improvement methodology that drives innovation and operational excellence. With 2024 revenues of $23.9 billion, the company ranks 180th on the Fortune 500 and plays a critical role in advancing scientific research, improving diagnostic capabilities, and accelerating the development of life-saving therapies.